TY - JOUR. T1 - Posttransplant diabetes mellitus in pediatric renal transplant recipients. T2 - A report of The North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). AU - Al-Uzri, Amira. AU - Stablein, Donald M.. AU - Cohn, Richard A.. PY - 2001/9/27. Y1 - 2001/9/27. N2 - Background. The incidence of renal post transplant diabetes mellitus (PTDM) in adults varies from 3-46%. Methods. We did a retrospective analysis of 1365 children in The North American Pediatric Renal Transplant Cooperative Study with renal transplant (Tx) reported between January 92 and July 1997. PTDM, defined as ,2 weeks of insulin therapy after Tx, developed in 36 patients. A control group of 153/1329 non-PTDM patients was selected and matched for age at Tx and primary diagnosis. Results. African-Americans were overrepresented (36.1 vs. 17.6%, P=0.017) and Hispanics were underrepresented (5.6 vs. 26.1%, P=0.019) among cases. Although prednisone dose 30 days post-Tx was higher among cases (0.89 mg/kg/day) ...
Introduction: The development of de novo donor-specific antibodies (dnDSA) has been associated with rejection and graft loss in kidney transplantation, and DSA screening is now recommended in all kidney transplant recipients. However, the clinical significance of dnDSA in patients with a stable creatinine remains unclear. Methods: We performed a retrospective cohort study of 103 patients receiving a first, kidney alone transplant between 12/1/2007 and 12/31/2013. Inclusion criteria were age ,18 years old at the time of transplant and at least two years of DSA monitoring. All patients underwent DSA screening every 3 months post-transplant with additional testing as clinically indicated. No treatment was given for DSAs in the absence of biopsy-proven rejection. Results: 20 patients (19%) developed dnDSA in the setting of a stable creatinine and 13 patients (13%) developed dnDSA in the setting of an elevated creatinine. Median follow-up time post-transplant was 4.1 (IQR 2.9-5.7) years. In a Cox ...
By B.DULGUUN. The first kidney transplant procedure in 1996 by Mongolian doctors was unsuccessful. After ten years, State Honored Doctor L.Jambaljav and his colleagues from the Mongolian National Central Hospital No.1 successfully conducted a kidney transplant procedure. Currently, State Honored Doctor and Professor of Chronic Kidney Disease Clinic D.Nyamsuren is working as the head of the Kidney Transplant Center team at the National Central Hospital. He has been working with the team since the introduction of kidney transplantation in Mongolia and saved 79 lives. Below is an interview with D.Nyamsuren about kidney transplantation in Mongolia.. -Whats the current actual cost of kidney transplantation?. -The National Central Hospital No.1 conducts kidney transplantation for 12 million MNT. Eight million is paid by the Ministry of Health package and the rest by the patient. At our current price, this budget is not sufficient. The National Central Hospital No.1 is able to transplant kidneys for ...
A three sequence, open-label, multi-center, prospective, study in stable kidney transplant patients to assess and compare the pharmacokinetics (Cmax, C24, and AUC), and safety of LCP-Tacro (tacrolimus) tablets versus Prograf (tacrolimus) capsules.. Stable kidney transplant patients who fulfill all I/E criteria will be enrolled and kept on Prograf for 7 days. Following a 24-hour PK study on Day 7 to determine pharmacokinetics for Prograf, all patients will be converted to once daily LCP-Tacro for 7 days with no dose changes allowed. On Day 14 and Day 21 a 24-hour LCP-Tacro PK study will be performed. On Day 22 patients will be converted back to their original twice daily dose of Prograf for a safety follow-up period of 30 days ending with a safety assessment on day 53. ...
Partial table of contents: A Short History of Renal Transplantation (R. Calne). Considerations in Organ Transplantation (R. Kerman). Pretransplantation and Posttransplantation Psychosocial Evaluation. (G. Wolff). Impact of Recipient Age on Renal Allograft Outcome (G. Arbus & D. Hebert). Steroid Withdrawal After Renal Transplantation (E. Ingulli & A. Tejani). Treatment of Acute Rejection (G. Offner). Urologic Complications in Renal Transplantation (O. Salvatierra). Noncompliance to Medical Regimens (B. Cole). Malignancy in Children (I. Penn). Long-Term Outcome of Kidney Transplantation in Children (D. Potter). Index.Pediatric Renal Transplantation, 1 was published 1994 under ISBN 9780471591207 and ISBN 0471591203. [read more] ...
PRIMARY OBJECTIVES:. I. To assess human papillomavirus (HPV) vaccine-type-specific seroconversion rates at 12-months post-transplantation among kidney transplant recipients who receive ,= 1 doses of the recombinant human papillomavirus nonavalent vaccine (Gardasil 9 HPV vaccine) ,= 30 days prior to transplantation.. SECONDARY OBJECTIVES:. I. To evaluate the following in adult kidney transplant recipients who receive ,= 1 doses of the Gardasil 9 HPV vaccine prior to transplantation:. Ia. HPV vaccine-type-specific seroconversion rates at 12-months post-transplantation.. Ib. Persistence and stability of HPV vaccine-type-specific geometric mean titers (GMT) at 6 and 12-months post-transplantation, and rise in HPV vaccine-type-specific GMT at the 13 month post-transplant visit.. Ic. Vaccine safety profile and allograft rejection/opportunistic infections stratified by number of vaccine doses and time between the last vaccine dose and the transplant procedure.. Id. HPV detection in self-collected ...
BACKGROUND: C-reactive protein (CRP) is a predictor of coronary heart disease, total mortality and chronic allograft nephropathy in renal transplant recipients. The determinants of CRP have been investigated in the general population, but not in renal transplant recipients. CRP might reflect metabolic aberrations in association with central obesity and systemic atherosclerosis. However, it may also reflect a low-grade immune-mediated response to the graft. In this study we investigated the factors associated with CRP in a renal transplant population. METHODS: Between August 2001 and July 2003, renal transplant recipients with a functioning graft for more than 1 year (n = 847) were eligible for investigation at their next visit to the outpatient clinic. A total of 606 patients (55% male, aged 51+/-12 years) participated at a median (interquartile range) time of 6.0 (2.6-11.4) years post-transplant. RESULTS: Median CRP concentration was 2.0 (0.80-4.8) mg/l and mean 24 h creatinine clearance was 62+/-22 ml
The ultimate goal of clinical transplantation is for the recipients to achieve long-term survival, with continuing graft function, that is equivalent to that of the age-matched general population. We studied subsequent outcome in kidney transplant recipients with 10 years of graft function. In all, 2202 kidney transplant recipients survived with graft function ,10 years. For 10-year survivors, the actuarial 25-year patient survival rate for primary transplant living donor (LD) recipients was 57%; graft survival, 43%. For primary transplant deceased donor (DD) recipients, the actuarial 25-year patient survival rate was 39%; graft survival, 27%. The two major causes of late graft loss were death (with graft function) and chronic allograft nephropathy (tubular atrophy and interstitial fibrosis). The two major causes of death with function were cardiovascular disease (CVD) and malignancy. For nondiabetic recipients, the mean age at death with function from CVD was 54 ± 13 years; for diabetic ...
Uremia has long been recognized to disrupt the normal physiology of numerous organs, including the heart (2,3). Over the last 30 years, echocardiography studies have found adverse changes in cardiac structure and function associated with end-stage renal disease (ESRD), which is collectively termed uremic cardiomyopathy. These cardiac abnormalities, including left ventricular hypertrophy and systolic dysfunction, are common in hemodialysis and are associated with an increased risk of adverse clinical outcomes (4). However, the precise nature of the uremic mediators of cardiac dysfunction remain elusive. Kidney transplantation is the treatment of choice for selected patients with ESRD. A successful kidney transplantation improves the quality of life and reduces the mortality risk for most patients compared with maintenance dialysis (5). However, 50% to 60% of deaths among kidney transplantation recipients are directly attributable to cardiovascular disease. In addition, death from cardiovascular ...
TY - JOUR. T1 - Early renal function recovery and long-term graft survival in kidney transplantation. AU - Wan, Susan S.. AU - Cantarovich, Marcelo. AU - Mucsi, I.. AU - Baran, Dana. AU - Paraskevas, Steven. AU - Tchervenkov, Jean. PY - 2016/5/1. Y1 - 2016/5/1. N2 - Following kidney transplantation (KTx), renal function improves gradually until a baseline eGFR is achieved. Whether or not a recipient achieves the best-predicted eGFR after KTx may have important implications for immediate patient management, as well as for long-term graft survival. The aim of this cohort study was to calculate the renal function recovery (RFR) based on recipient and donor eGFR and to evaluate the association between RFR and long-term death-censored graft failure (DCGF). We studied 790 KTx recipients between January 1990 and August 2014. The last donor SCr prior to organ procurement was used to estimate donor GFR. Recipient eGFR was calculated using the average of the best three SCr values observed during the first ...
The Banff Classification is a schema for nomenclature and classification of renal allograft pathology, established in 1991 by Kim Solez and Lorraine C. Racusen in Banff, Canada. The initiative was "inspired by the then recent development of a consensus grading system for diagnosis of rejection in cardiac allografts led by Dr Margaret Billingham, a key participant at the first Banff meeting". Prior the Banff Classification there was no standardized, international classification for renal allograft biopsies, which resulted in considerable heterogeneity among pathologists in characterization of renal allograft biopsies. The first Banff schema was published in 1993, and has since undergone updates at regular intervals. The classification is expanded and updated every two years in meetings organized by the Banff Foundation for Allograft Pathology. An evaluation of the Banff Classification in March 2000 confirmed significant association between the revised Banff 97 classification and graft outcome. ...
Background: Cardiovascular complications are the leading cause of mortality in end-stage renal disease (ESRD) patients. This study aimed to evaluate the efficacy of kidney transplantation on the cardiovascular status in ESRD patients. Methods: During 2012 to 2014 and in a cross-sectional study, 181 patients were randomly selected for this study. All patients were followed for periods of 6 and 12 months after kidney transplantation. The patients with ESRD and kidney transplant recipients; the patients with left ventricle ejection fraction [Med Arch 2017; 71(6.000): 408-411]. Keywords: End-stage renal disease, Echocardiography, Kidney transplantation, Cardiovascular disease. >>Full text PDF >>Abstract >>(10.5455/medarh.2017.71.408-411). ...
Requiring a formal patient education class may help reduce disparities in kidney failure patients access to kidney transplantation.. Being educated about your health and your treatment options is a good thing. According to a new study, kidney failure patients who take part in an education program are more likely to get evaluated for a kidney transplant. The study appears in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that requiring a formal patient education class may help reduce inequities in kidney failure patients access to kidney transplantation.. Kidney transplantation is the preferred treatment for kidney failure. Among kidney failure patients, blacks are less likely to receive kidney transplants than whites for reasons that are unclear. Unfortunately, few published studies have looked at interventions that might reduce such racial disparities in access to kidney transplantation.. In an attempt to educate patients about the ...
OBJECTIVE Renal transplantation with a well-functioning graft leads to a rapid restoration of endocrine and sexual functions. The aim of this study was to examine our experience with pregnancies among renal transplant patients, particularly with regard to their impact on graft function. PATIENTS AND METHODS We analyzed 10 pregnancies in 7 renal transplant recipients for long-term graft outcomes in terms of clinical and biological data. RESULTS The mean patient age was 28.5 +/- 4 years. They all received a living donor kidney. The time between transplantation and the onset of pregnancy was 33.4 +/- 23.2 months. Regarding the immunosuppressive therapy, all patients received steroids and cyclosporine; 4 patients received in addition azathioprine and 2 received mycophenolate mofetil that was changed at 1 month before conception to azathioprine. There was no significant difference between the serum creatinine before and during pregnancy. We did not observe any acute rejection episode. Pregnancy
Avoiding HLA-DR mismatching appears to be beneficial in pediatric kidney transplant patients, however the likelihood of finding a matching donor must be considered against the wait time for a possible donation, according to a report in the July issue of Archives of Surgery, one of the JAMA/Archives journals.. "Although avoiding HLA [human leukocyte antigen; cell surface antigens that regulate host cell responses to transplanted cells] antigen mismatching has been shown to benefit long-term graft survival, it has raised concerns about disadvantaging minority groups, particularly black patients, and pediatric patients, who have severe growth retardation and other problems when dialysis is prolonged before transplantation," the authors write as background information in the article. "Currently, only HLA-DR matching is considered in the United Network for Organ Sharing (UNOS) organ allocation system.". To examine the relationship between HLA-DR mismatching and rejection, graft survival and ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
A kidney transplant is a life-changing and life-saving procedure. Yet, a new study conducted by Mayo Clinic and the University of Michigan shows that only one-third of patients who ultimately receive a living donor kidney transplant receive it pre-emptively (i.e., before starting dialysis). Less than two-thirds receive a transplant either pre-emptively or within a year of starting dialysis.. Existing research suggests that less time spent on dialysis before transplant can improve patient outcomes and survival after transplant. However, this new research shows there has been no increase in the utilization of what is known as timely living donor kidney transplants, which includes pre-emptive and early transplants, since 2006. The study "Under-utilization of timely kidney transplants in those with living donors," was published recently in the American Journal of Transplantation.. Read more. ...
TY - JOUR. T1 - Cancer and mTOR inhibitors in kidney transplantation recipients. AU - Kao, Chih Chin. AU - Liu, Jia Sin. AU - Chang, Yu Kang. AU - Lin, Ming Huang. AU - Lin, Yen Chung. AU - Chen, Hsi Hsien. AU - Chang, Wei Chiao. AU - Hsu, Chih Cheng. AU - Wu, Mai Szu. PY - 2018/1/1. Y1 - 2018/1/1. N2 - Background: Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. Methods: In the current study, patients were registered into a national database in Taiwan. Between year 2000 and 2013, 4,563 patients received kidney transplantation. They were divided into two groups, according to mTOR inhibitors usage. The cumulative dose of mTOR inhibitors was recorded. Patients were followed-up until de novo cancer development, death, or the end of 2014. Results: Patients were divided into two groups: mTOR inhibitors users (study group, ...
TY - JOUR. T1 - Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. AU - Palmer, B. F.. AU - Toto, R. D.. PY - 1991. Y1 - 1991. N2 - Cyclosporine A (CyA) is a potent immunosuppressive agent that is used in organ transplantation and in a variety of immunological diseases. It has a variety of adverse side effects, some of which can be serious and even life-threatening. CyA-associated neurotoxicity is generally mild, consisting of fine tremor. However, more complex neurologic abnormalities, including motor spinal cord and cerebellar syndromes, have rarely been described in bone marrow and liver transplant patients. Renal transplant patients have been spared from such CyA-induced toxicity. In this report, three renal transplant patients are described who developed complex and severe neurologic toxicity in the setting of therapeutic blood levels of CyA, which was completely reversible on discontinuation of the drug. No patient had a prior history of neurological ...
TY - JOUR. T1 - Kidney allograft survival outcomes in combined intestinal-kidney transplant. T2 - An analysis of the UNOS/OPTN database 2000-2014. AU - Moinuddin, Irfan. AU - Yaqub, Muhammad Sohail. AU - Taber, Tim. AU - Mujtaba, Muhammad. AU - Sharfuddin, Asif. PY - 2018/1/1. Y1 - 2018/1/1. N2 - Background and objectives: Intestinal transplants carry a high morbidity/mortality. Kidney allograft outcomes after combined intestinal (IT) with kidney transplant (CIKT) remain largely uninvestigated. Materials and methods: The UNOS STAR database was queried to identify all such combined organ transplants from 2000 to 2015. Results: Out of a total 2215 (51.4% peds vs 48.6% adults) intestinal transplants, 111 (5.0%) CIKT were identified (32.4% peds vs 67.6% adults). Over the study period of CIKT, a total of 45.9% of these cases died with a functioning kidney graft. DGF rate was 9.0%. The 1-year reported kidney acute rejection rate was 6.3%. For the entire CIKT population over the entire study era, the ...
EBV viremia occurs frequently after transplantation and can be related to post-transplant lymphoproliferative disorders (PTLD). However, the consequences of the majority of viremia are unclear. Barnoulid et al. followed EBV viral loads in 383 kidney transplant patients during the first year post-transplant. 40% of patients had at least one detected viremia; viremia was more common in EBV mismatched patients and those that received ATG. While these risk factors for EBV are well known, the authors also found that EBV infection was associated with opportunistic infection and graft loss. This study adds to our knowledge on EBV although further work is necessary to determine what to do with patients who had chronic low level viremia.. ...
A free platform for explaining your research in plain language, and managing how you communicate around it - so you can understand how best to increase its impact.
Definition of kidney transplantation in the Definitions.net dictionary. Meaning of kidney transplantation. What does kidney transplantation mean? Information and translations of kidney transplantation in the most comprehensive dictionary definitions resource on the web.
As Dr. Cooper took on this new role, the Division also hired two new physicians so that we can offer patients a full team of experts and comprehensive care.. Dr. Charles Strom is a transplant surgeon specializing in kidney transplants. After earning his medical degree from the University of Massachusetts Medical School, he completed his general surgery residency at St. Elizabeths Medical Center in Boston and his fellowship in abdominal transplant surgery at the Massachusetts General Hospital, where he was recognized as the top teaching fellow in the Partners system. His clinical interests include kidney transplantation, laparoscopic donor nephrectomy, dialysis access surgery, and general surgery in patients with kidney and liver failure. Dr. Nitender Goyal is a nephrologist specializing in kidney and pancreas transplantation, living kidney donation, highly sensitized kidney transplant recipients and kidney paired exchange. He completed his training at B.J Medical College in India, Steward ...
Approximately 17,000 kidney transplants occur each year in the United States, accounting for almost 60% of all organ transplants. Kidney transplantation is the treatment of choice for end stage renal disease. Causes of renal failure are varied, including diabetes, hypertension, glomerular and cystic kidney diseases, and autoimmune disorders. Kidney transplantation offers a better quality of life and a survival benefit for most patients. The 2012 Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) annual report showed that the conditional graft half-life (defined as the time to when half of the grafts surviving at least one year are still functioning) was 12.5 years for deceased donor transplants and 15.3 years for living donor transplants in 2009-2010. Survival rates continue to improve; a recent analysis of more than 250,000 kidney transplant recipients demonstrated that death-censored graft half-life for all deceased donor transplants increased
Background. Chronic allograft nephropathy (CAN) is the leading cause of late allograft failure, with only limited treatment options. Blockade of the renin-angiotensin system (RAS) decreases progression in diabetic and non-diabetic renal disease, but the effect on CAN is as yet unclear. Therefore, we have studied retrospectively the effect of RAS blockade on renal survival in patients with biopsy-proven CAN.. Methods. The medical records of 72 patients with biopsy-proven CAN were evaluated with regard to time course of graft function, proteinuria, blood pressure, and antihypertensive and immunosuppressive treatment. Coxs proportional hazards model was used for analysing renal graft survival after the index biopsy.. Results. On univariate analysis, histological determinants influencing renal survival were the chronic interstitial and chronic tubular score, and clinical parameters were the serum creatinine level at the time of the biopsy, the relative change in serum creatinine level between 12 ...
BACKGROUND: Chronic transplant dysfunction is characterized by a gradual decline in renal function with slowly rising serum creatinine. The underlying mechanism is thought to include inflammation and atherosclerosis. C-reactive protein (CRP) is a well-established marker of both inflammation and atherosclerosis. In this prospective study, we investigated whether CRP could be of use as a clinical marker for early identification of renal transplant recipients at increased risk of deterioration of graft function. METHODS: In this prospective study, all participating patients (n = 606) visited the out-patient clinic at least once a year, and serum creatinine was assessed at every visit. Subjects with a follow-up of |1 year (n = 31) were excluded from analysis. RESULTS: A total of 575 patients participated at a median (interquartile range) time of 5.9 (2.6-11.3) years post-transplantation. Median time of follow-up was 3.0 (2.4-3.4) years. Changes in serum creatinine during follow-up were -0.45 (-4.83-4.76)
Over a period of two years thirty five renal allograft recipients & donors were evaluated to find out the aetiology of early renal allograft dysfunction, in the Department of Nephrology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh from March 2010 to February 2012. A comparison was made between dysfunction & functioning graft group. Mean age of recipients were (36.4±9.4) years, mean age of donors were (41.7±8.3) years, with a male and female ratio of 3:1. Fifty percent recipients showed one heliotype match, ninety percent recipients were anti CMV antibody IgG positive, few were anti CMV antibody IgM positive. All kidney transplant recipients received same immunosuppressive drugs. Primary disease of the renal allograft recipients demonstrates that majority 88.58% had glomerulonephritis, 5.72% had polycystic kidney disease, 2.85% had chronic pyelonephritis and another 2.85% had diabetic nephropathy. Among 35 renal allograft recipients 23(66%) showed early graft dysfunction, ...
Background Calcineurin inhibitor (CNI) therapy is known to induce nephrotoxicity in a dose-dependent manner. Nevertheless, improvements in graft function following elimination or reduction of CNI exposure in long-term kidney transplant recipients remains unclear. Furthermore, benefits of conversion from CNI to mammalian target of rapamycin inhibitor-based immunosuppression in long-term kidney transplant patients remain uncertain. The current study addressed this hypothesis.
Renal transplantation immunology - Vaccination after transplantation - Kidney transplantation: the surgery - Immunosuppressive therapy in renal transplant patients - Diagnosis and treatment of transplant rejection - Suggested renal transplant recipient discharge follow-up - Recurrent and de novo renal disease following renal transplantation - Urinary tract infection post-transplantation - New onset diabetes after transplantation - Infection post-transplantation - Malignancy following renal transplantation - Graft survival in transplant recipients ...
Expanded criteria donors (ECDs) and donation after cardiac death (DCD) provide more kidneys in the donor pool. However, the financial impact and the long-term benefits of these kidneys have been questioned. From 1998 to 2005, we performed 271 deceased donor kidney transplants into adult recipients. …
Abstract of Paper: STUDY OF POST-TRANSPLANT DIABETES MELLITUS IN LIVE - DONOR KIDNEY TRANSPLANT RECIPIENTS , Author: El-Metwally El-Shahawy MD, Sameh Bahgat MD, Hassan Galal MD, Amro Afifi MD, Ashraf Talaat MD, Ehab Wahba Wafa MD* and Ayman Fathi MD* , Year: 2005 , Faculty of Medicine, Benha University
Background. Benefits of conversion from calcineurin inhibitor (CNI) to mammalian target of rapamycin inhibitor-based immunosuppression in long-term kidney transplant patients remain uncertain. Methods. ASCERTAIN was a 24-month, open-label, multicenter study. Kidney transplant patients more than 6 months posttransplant receiving CNI (baseline glomerular filtration rate [GFR] 30-70 mL/min/1.73 m(2)) were randomized to everolimus with CNI elimination (n = 127) or CNI minimization (n = 144), or continued CNI unchanged (controls, n = 123) to assess the effect on measured GFR at month 24 after randomization. Results. Renal function was stable in all groups to month 24. Mean measured GFR at month 24, the primary endpoint, was 48.0 +/- 22.0 mL/min/1.73 m(2), 46.6 +/- 21.1 mL/min/1.73 m(2), and 46.0 +/- 20.4 mL/min/1.73 m(2) in the CNI elimination, CNI minimization, and control groups, respectively. Differences between CNI elimination (1.12 mL/min/1.73 m(2), 95% confidence interval [CI] -3.51 to 5.76, ...
Sellarés, J., Reeve, J., Loupy, A., Mengel, M., Sis, B., Skene, A., de Freitas, D. G., Kreepala, C., Hidalgo, L. G., Famulski, K. S. and Halloran, P. F. (2013), Molecular Diagnosis of Antibody-Mediated Rejection in Human Kidney Transplants. American Journal of Transplantation, 13: 971-983. doi: 10.1111/ajt.12150 ...
TY - JOUR. T1 - Isometric tubular epithelial vacuolization in renal allograft biopsy specimens of patients receiving low-dose intravenous immunoglobulin for a positive crossmatch. AU - Haas, Mark. AU - Sonnenday, Christopher J.. AU - Cicone, Jeffrey S.. AU - Rabb, Hamid. AU - Montgomery, Robert A.. PY - 2004/8/27. Y1 - 2004/8/27. N2 - Background. Perioperative treatment with plasmapheresis and intravenous immunoglobulin (IVIG), combined with a tacrolimus-based immunosuppressive regimen, has been used successfully to allow renal transplantations in crossmatch-positive recipients. A common finding in biopsy specimens of these allografts is isometric vacuolization of proximal tubular epithelium. This finding presents a diagnostic dilemma because it may occur secondary to IVIG treatment or tacrolimus nephrotoxicity. Methods. We compared the frequency and severity of isometric tubular vacuolization in renal allograft biopsy specimens obtained during the first 10 days after transplantation in 24 ...
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.. Get Sample Report @ https://www.htfmarketreport.com/sample-report/84578-kidney-transplant-market. Kidney Transplant Performed Analysis: United States is the leading kidney transplant performed with more than 40% share in 2015. The number of Kidney transplant done in 10 countries covered in the report was more than 40 Thousand in 2015. Brazil is the second leading kidney transplant ...
By Swedish News. SEATTLE - November 7, 2013 - Swedish Medical Centers organ transplant program is celebrating two milestones this month - the 40th anniversary of its kidney transplant program and recent approval of its liver transplant program by Medicare.. Swedish is a longstanding leader in organ transplantation in the Pacific Northwest, particularly kidney transplantation. Now operating for 40 years, the kidney transplant program is the most experienced of its kind in the region treating more than 100 patients each year.. The recent approval by Medicare comes five years after the Washington Supreme Court approved the liver programs certificate of need in 2008. The first liver transplant performed at Swedish was in September 2010.. "It has been an incredible journey," said Dr. Marquis Hart, director of the organ transplant program at Swedish. "But the outcome has been phenomenal. During the last three years, our liver program has hit the ground running and seen outcomes that well surpass ...
Several randomized controlled trials have shown lower rates of non-melanoma skin cancer among patients who receive sirolimus from the time of transplant. This study randomized previously transplanted patients who had previously had at least one skin cancer to either continue on their usual immunosuppression or change their calcineurin inhibitor to sirolimus. There were fewer new skin cancers in the sirolimus group and suggests a possible strategy to reduce this complication in patients at high risk post-transplant.. ...
Currently, there are approximately 96,000 people in the U.S. waiting for a kidney transplant.1 The waiting list is long because there are limited renal donors, and dialysis prolongs the lives of individuals with end stage renal disease (ESRD) allowing patients to wait a longer period of time before an organ becomes available. The waiting period for a kidney ranges from 5 to 10 years depending upon the state in which the transplant will take place. In spite of the odds, a renal transplant is the preferred treatment for patients with ESRD.2,3. Patients with ESRD are at high risk for oral infections due to use of immunosuppressants and from complications related to comorbidities and/or from secondary developing medical conditions. These conditions include diabetes mellitus, hypertension, chronic glomerulonephritis, systemic lupus erythematosus, anemia and hyperparathyroidism, all of which may compromise both oral and overall health and longevity.1,4,5 Therefore, to provide safe, high-quality care ...
The studys authors said the findings suggest that, as is the case in adults, whenever possible, children should not be placed on a certain type of dialysis prior to transplantation.. "Children who face kidney transplant fare best when they receive the organ without undergoing dialysis," said Lavjay Butani, professor of pediatric nephrology in the UC Davis School of Medicine and chief of pediatric nephrology at UC Davis Childrens Hospital. "The longer the dialysis prior to the operation, the worse is the survival of the kidneys.". The study, "The Effect of Pre-transplant Dialysis Modality and Duration on Long-term Outcomes of Children Receiving Renal Transplants," is published online in the journal Transplantation. It is one of the largest-ever on outcomes in children whose kidney transplants took place prior to dialysis, known as pre-emptive transplants.. The study examined the effects of hemodialysis, a method for removing waste products such as creatinine and urea, as well as free, water ...
The goal of kidney transplantation is to restore patients physical function and decrease their dependence upon medical services. Rehospitalization following kidney transplant surgery is a recurrent and costly event that detracts from the ultimate aims of the intervention. The purposes of this retrospective cohort study were to: (1) estimate the rate of rehospitalization for kidney transplant recipients during 90 days following transplantation; (2) identify the reasons for readmission; and (3) identify patient-specific factors, identifiable at time of discharge, that are associated with the likelihood of rehospitalization. Twenty-two demographic and clinical factors were examined in a consecutive series of 300 patients who received kidney transplants between March 1995 and February 1997. The mean age of patients was 46.9 years (SD = 12.59). The median length of initial hospital was 9 days(IQ range = 7-15). One hundred sixty-one patients (53.7%) experienced 267 readmissions during the first 90 ...
BACKGROUND Despite significant improvements in life expectancy of kidney transplant patients due to advances in surgery and immunosuppression, Chronic Allograft Nephropathy (CAN) remains a daunting problem. A complex network of cellular mechanisms in both graft and peripheral immune compartments complicates the non-invasive diagnosis of CAN, which still requires biopsy histology. This is compounded by non-immunological factors contributing to graft injury. There is a pressing need to identify and validate minimally invasive biomarkers for CAN to serve as early predictors of graft loss and as metrics for managing long-term immunosuppression. METHODS We used DNA microarrays, tandem mass spectroscopy proteomics and bioinformatics to identify genomic and proteomic markers of mild and moderate/severe CAN in peripheral blood of two distinct cohorts (n = 77 total) of kidney transplant patients with biopsy-documented histology. FINDINGS Gene expression profiles reveal over 2400 genes for mild CAN, and over
Living-related kidney transplantation (costs for program #56811) ✔ Klinik Belair ✔ Department of Urology ✔ BookingHealth.com
TY - JOUR. T1 - Factors associated with failure to list hiv-positive kidney transplant candidates. AU - Sawinski, D.. AU - Wyatt, C. M.. AU - Casagrande, L.. AU - Myoung, P.. AU - Bijan, I.. AU - Akalin, Enver. AU - Schröppel, B.. AU - Deboccardo, G.. AU - Sehgal, V.. AU - Dinavahi, R.. AU - Lerner, S.. AU - Ames, S.. AU - Bromberg, J.. AU - Huprikar, S.. AU - Keller, Marla J.. AU - Murphy, B.. PY - 2009/6. Y1 - 2009/6. N2 - With improved survival in the antiretroviral era, data from ongoing studies suggest that HIV patients can be safely transplanted. The disproportionate burden of HIV-related end-stage renal disease in minority populations may impose additional obstacles to successful completion of the transplant evaluation. We retrospectively reviewed 309 potentially eligible HIV patients evaluated for kidney transplant at our institution since 2000. Only 20% of HIV patients have been listed, compared to 73% of HIV-negative patients evaluated over the same period (p , 0.00001). Failure to ...
Doctors at Columbia Asia Hospital in Patiala specializing in nephrology and renal transplant are here to walk you through kidney transplant cost in india, the procedures involved with dialysis, organ transplantation, etc.
Doctors at Columbia Asia Hospital in Gurgaon specializing in nephrology and renal transplant are here to walk you through kidney transplant cost in India, the procedures involved with dialysis, organ transplantation, etc.
In this post, well make a thorough review of kidney transplantation as a treatment alternative for patients with ESRD. Kidney transplantation in the treatment of CKD Numerous studies have shown that renal transplantation is a therapy that improves long-term survival when compared with maintenance dialysis. Transplantation in a predialysis situation is an attractive option because…
For the first time, an immunosuppressive agent has shown better organ survival in kidney transplant recipients than a calcineurin inhibitor, the current standard of care, according to a worldwide study led by UC San Francisco and Emory University investigators.. The study of the drug belatacept, which carries short-term risks that include an increased possibility for a certain cancer, appears in the Jan. 28 issue of the New England Journal of Medicine.. "Belatacept is potentially a transformational drug in kidney transplantation because unlike the currently used calcineurin inhibitor drugs cyclosporine and tacrolimus, it is not toxic to the kidney," said lead author Flavio Vincenti, MD, a UCSF Health kidney and pancreas transplant specialist. "In fact, it helps preserve the function of the kidney over the long term and is more effective in suppressing antibodies against the kidney, which are important causes of late graft loss.". Kidney transplant recipients need to take drugs to prevent their ...
This study shows that allowing for the competing risk of death in a risk factor study of first DSCGL in stable renal transplant recipients yields different risk associations compared with a standard model. Serum creatinine was the most susceptible to competing risk adjustments, losing 40% of its associated strength when adjusted for death. This is likely to reflect the fact that poor renal function is the leading risk factor for graft failure, but it shows a weaker association with risk of mortality. At the start of follow-up, the effect of competition is small because mortality is low. With time, however, the effect of competing risk increases. This is analogous to the situation in which a confounding variable becomes stronger with time, which usually results in weakening of the regression association across the whole follow-up period. However, the confounding effect of mortality is more complex because individual risk factors are associated to a varying degree to competing outcomes ...
Background Renal transplantation is associated with an increased risk for premature cardiovascular disease. We analyzed the data in the placebo arm of Assessment of Lescol in Renal Transplantation (ALERT) to improve our understanding of the relationship between cardiovascular risk factors and outcomes in this unique population. Methods: We performed Cox survival analysis for myocardial infarction, cardiac death, and noncardiac death in 1,052 patients recruited to the placebo arm of ALERT. These subjects were aged 30 to 75 years, had stable graft function at least 6 months after transplantation, had a serum total cholesterol level between 155 and 348 mg/dL (4 and 9 mmol/L), and were receiving cyclosporine-based immunosuppression. Results: The results confirm previous studies. In multivarlate analysis, preexisting coronary heart disease (hazard ratio [HR], 3.69, P < 0.001), total cholesterol level (HR, 1.55 per 50 mg/dL, P = 0.0045), and prior acute rejection (HR, 2.36, P = 0.0023) were ...